PRESS RELEASE published on 03/14/2025 at 17:45, 10 months 22 days ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics lance un processus de recherche de repreneurs dans le cadre de son redressement judiciaire. Appel d'offres ouvert jusqu'au 11 avril 2025 Appel D'offres Redressement Judiciaire Repreneurs Procédure PHAXIAM Therapeutics
BRIEF published on 03/06/2025 at 18:01, 10 months 30 days ago PHAXIAM Therapeutics entre en redressement judiciaire et retarde ses résultats financiers Retard Des Résultats Financiers Administrateur Judiciaire Suspension Des Échanges Mise Sous Séquestre De PHAXIAM Défis Biotechnologiques
BRIEF published on 03/06/2025 at 18:01, 10 months 30 days ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 10 months 30 days ago Informations privilégiées / Autres communiqués PHAXIAM annonce l'ouverture d'une procédure de redressement judiciaire et le report de la publication de ses résultats financiers 2024. La Société se place sous la protection du Tribunal de commerce de Lyon Résultats Financiers Tribunal De Commerce Redressement Judiciaire PHAXIAM Procédure
PRESS RELEASE published on 03/06/2025 at 17:56, 10 months 30 days ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 10 months 30 days ago Suspension de la Cotation de PHAXIAM Therapeutics Euronext Paris Biopharmaceutique Suspension Cotation PHAXIAM Therapeutics Infections Résistantes
BRIEF published on 03/06/2025 at 11:45, 10 months 30 days ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
PRESS RELEASE published on 03/06/2025 at 11:40, 10 months 30 days ago Informations privilégiées / Autres communiqués PHAXIAM Therapeutics suspend sa cotation sur Euronext Paris en attendant un prochain communiqué. La société développe des traitements innovants contre les infections bactériennes Cotation Suspension Traitements Innovants PHAXIAM Therapeutics Infections Bactériennes
BRIEF published on 12/30/2024 at 17:50, 1 year 1 month ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
BRIEF published on 12/30/2024 at 17:50, 1 year 1 month ago PHAXIAM Therapeutics : résultats prometteurs de l’étude pilote PhagoDAIR PHAXIAM Therapeutics Étude PhagoDAIR Phages Anti-S. Aureus Phase II GLORIA Contrôle De L'infection
Published on 02/05/2026 at 17:35, 1 hour 9 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 2 hours 4 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 2 hours 59 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 3 hours 34 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 3 hours 54 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 18:09, 34 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 48 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 1 hour 4 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 1 hour 4 minutes ago UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI
Published on 02/05/2026 at 17:05, 1 hour 38 minutes ago European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
Published on 02/05/2026 at 18:06, 37 minutes ago Aéroports de Paris SA - Actions et droits de vote au 31 janvier 2026
Published on 02/05/2026 at 18:06, 37 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 January 2026
Published on 02/05/2026 at 18:00, 44 minutes ago Information concerning the total number of voting rights and shares in the share capital as of January 30, 2026
